Tafinlar - dabrafenib
Navigation: NDC > Supplier starting with: G > GLAXOSMITHKLINE LLC| Field | Value |
|---|---|
| NDC Code: | 0173-0846 |
| Proprietary Name: | Tafinlar |
| Suffix: | |
| Non-Proprietary Name: | dabrafenib |
| Dosage Form: | CAPSULE |
| Method: | ORAL |
| Original Marketing Date: | 10-06-2013 |
| Category Name: | NDA |
| Application Number: | NDA202806 |
| Labeler: | GLAXOSMITHKLINE LLC |
| Substance Name: | DABRAFENIB MESYLATE |
| Active Numerator Strength: | 50 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C8 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA] |
| DEA Schedule: |